{"nct_id":"NCT05885555","title":"A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-08-16","start_date_type":"ACTUAL","primary_completion_date":"2025-02-05","primary_completion_date_type":"ACTUAL","completion_date":"2029-03-19","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}